Dieter Tulkens

Mr. Dieter Tulkens

Ghent University, Ghent, Belgium
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2020 in Oncogene
Verified
Journal Article
Closed access
PDF file
TNThomas Naert
Thomas Naert
DDDionysia Dimitrakopoulou
Dionysia Dimitrakopoulou
DTDieter Tulkens
Dieter Tulkens
SDSuzan Demuynck
Suzan Demuynck
MCMarjolein Carron
Marjolein Carron
Kris VleminckxKris Vleminckx
Kris Vleminckx

30 June 2020 in Frontiers in Plant Science
Verified
Journal Article
Open access
PDF file
JWJocelyn De Wever
Jocelyn De Wever
DTDieter Tulkens
Dieter Tulkens
JVJan Verwaeren
Jan Verwaeren
HEHelena Everaert
Helena Everaert
HRHayley Rottiers
Hayley Rottiers
KMKathy Messens
Kathy Messens
Despite the high economic importance of cacao beans, few RNA-based studies have been conducted on this plant material and hence no optimal RNA-extraction has been reported. Moreover, extraction of high-quality RNA from recalcitrant cacao bean tissue has shown many difficulties and requires optimization. Furthermore, cacao beans are mostly found at remote and under-resourced locations, which pressures the outsourcing of such analysis and thereby demands RNA-stable preservation and transportation of cacao beans. This study aims to select an appropriate RNA extraction and preservation/transportation method for cacao beans. For this purpose, three sample homogenization and five extraction protocols on cacao beans were compared. In addition, 13 preservation conditions—differing in tissue crushing degree, preservation method, duration, and temperature—were compared and evaluated. A comparative analysis revealed that CTAB-based homogenization and extraction outcompeted all tested commercial protocols in RNA yield and integrity, respectively. Preservation at −80°C affected RNA quality the least, whereas freeze-drying was most suitable for transportation at room temperature for maximum 1 week. The cacao bean RNA obtained from the selected methods were compatible for downstream applications. The results of this study will facilitate on-field sampling and transportation of genetically sensitive cacao material prior to cacao bean transcriptomic studies. In addition, valuable insights on sample homogenization, extraction, preservation, and transportation have been provided, which is of interest to every plant geneticist.

4 October 2023 in Leukemia
Verified
Journal Article
Closed access
PDF file
DTDieter Tulkens
Dieter Tulkens
MBMarthe Boelens
Marthe Boelens
TNThomas Naert
Thomas Naert
MCMarjolein Carron
Marjolein Carron
SDSuzan Demuynck
Suzan Demuynck
Kris VleminckxKris Vleminckx
Kris Vleminckx

20 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
DTDieter Tulkens
Dieter Tulkens
DDDionysia Dimitrakopoulou
Dionysia Dimitrakopoulou
MBMarthe Boelens
Marthe Boelens
TNTom Van Nieuwenhuysen
Tom Van Nieuwenhuysen
SDSuzan Demuynck
Suzan Demuynck
Kris VleminckxKris Vleminckx
Kris Vleminckx
Modeling human genetic diseases and cancer in lab animals has been greatly aided by the emergence of genetic engineering tools such as TALENs and CRISPR/Cas9. We have previously demonstrated the ease with which genetically engineered Xenopus models (GEXM) can be generated via injection of early embryos with Cas9 recombinant protein loaded with sgRNAs targeting single or multiple tumor suppressor genes. What has been lacking so far is the possibility to propagate and characterize the induced cancers via transplantation. Here, we describe the generation of a rag2 knockout line in Xenopus tropicalis that is deficient in functional T and B cells. This line was validated by means of allografting experiments with primary tp53−/− and apc+/−/tp53−/− donor tumors. In addition, we optimized available protocols for the sub-lethal irradiation of wild-type X. tropicalis froglets. Irradiated animals also allowed the stable, albeit transient, engraftment of transplanted X. tropicalis tumor cells. The novel rag2−/− line and the irradiated wild-type froglets will further expand the experimental toolbox in the diploid amphibian X. tropicalis and help to establish it as a versatile and relevant model for exploring human cancer.

19 April 2022
Verified
Book Chapter
Open access
PDF file
DTDieter Tulkens
Dieter Tulkens
Kris VleminckxKris Vleminckx
Kris Vleminckx
Xenopus has made many seminal contributions to numerous research fields and has been especially critical for deciphering early vertebrate development. With the emergence of zinc finger nucleases (ZFNs), TALENs, and CRISPR/Cas9 techniques, Xenopus is receiving increased attention with regard to modeling of human diseases, including cancer. X. tropicalis is especially uniquely placed for these applications because it combines the general amphibian features of large externally developing embryos, which are straightforward to inject with genome editing reagents, with a relatively short life cycle and a true diploid genome. The generation of cancer-prone lines carrying a heterozygous mutant tumor suppressor gene (TSG) allows the modeling of hereditary cancer-predisposition syndromes. Alternatively, injection of multiplexed genome editing reagents and rapid F0 screening of such mosaic mutant animals allows the experimental investigation of cooperative tumor suppressive activity of multiple genes in specific cancer contexts, thereby allowing the identification or confirmation of novel driver gene mutations. Furthermore, via the generation of mosaic mutant X. tropicalis tumor models, it is possible to design strategies to identify cancer dependencies built on principles of cell-specific clonal selection. In addition, possibilities for in vivo compound treatments are highlighted. Finally, this chapter provides perspectives for novel tools that will facilitate future in vivo monitoring of tumor progression as well as precise genome editing techniques that can be useful for generating genetically engineered Xenopus models (GEXMs) even more closely mimicking the patient situation.

1 April 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
TNThomas Naert
Thomas Naert
DTDieter Tulkens
Dieter Tulkens
TNTom Van Nieuwenhuysen
Tom Van Nieuwenhuysen
JPJoanna Przybyl
Joanna Przybyl
SDSuzan Demuynck
Suzan Demuynck
DDDionysia Dimitrakopoulou
Dionysia Dimitrakopoulou
Cancer precision medicine implies identification of tumor-specific vulnerabilities associated with defined oncogenic pathways. Desmoid tumors are soft-tissue neoplasms strictly driven by Wnt signaling network hyperactivation. Despite this clearly defined genetic etiology and the strict and unique implication of the Wnt/β-catenin pathway, no specific molecular targets for these tumors have been identified. To address this caveat, we developed fast and semi-high throughput genetic Xenopus tropicalis desmoid tumor models to identify and characterize novel drug targets. We used multiplexed CRISPR/Cas9 genome editing in these models to simultaneously target a tumor suppressor gene ( apc ) and candidate dependency genes. Our methodology CRISPR/Cas9 Selection mediated Identification of Dependencies (CRISPR-SID) uses calculated deviations between experimentally observed gene editing outcomes and deep-learning-predicted double strand break repair patterns, to identify genes under negative selection during tumorigenesis. This revealed EZH2 and SUZ12 , both encoding polycomb repressive complex 2 components, and the transcription factor CREB3L1 , as genetic dependencies for desmoid tumors. In vivo EZH2 inhibition by Tazemetostat induced partial regression of established autochthonous tumors. In vitro models of patient desmoid tumor cells revealed a direct effect of Tazemetostat on Wnt pathway activity. CRISPR-SID represents a potent novel approach for in vivo mapping of tumor vulnerabilities and drug target identification. Significance Statement: CRISPR-SID was established in the diploid frog Xenopus tropicalis for in vivo elucidation of cancer cell vulnerabilities. CRISPR-SID uses deep learning predictions and binomial theory to identify genes under positive or negative selection during autochthonous tumor development. Using CRISPR-SID in a genetic model for desmoid tumors, treatment-recalcitrant mesenchymal tumors driven by hyper-activation of the Wnt signaling pathway, we identified EZH2 and SUZ12 , both encoding critical components of the polycomb repressive complex 2, as dependency genes for desmoid. Finally, we demonstrate the promise of EZH2 inhibition as a novel therapeutic strategy for desmoid tumors. With the simplicity of CRISPR sgRNA multiplexing in Xenopus embryos the CRISPR-SID method may be applicable to reveal vulnerabilities in other tumor types.